1 July 2023 false No description of principal activity Taxfiler 2024.6 07285425business:PrivateLimitedCompanyLtd2023-07-012024-10-31 072854252023-06-30 072854252023-07-012024-10-31 07285425business:AuditExemptWithAccountantsReport2023-07-012024-10-31 07285425business:FilletedAccounts2023-07-012024-10-31 072854252024-10-31 07285425business:Director12023-07-012024-10-31 07285425business:RegisteredOffice2023-07-012024-10-31 072854252023-06-30 07285425core:WithinOneYear2024-10-31 07285425core:WithinOneYear2023-06-30 07285425core:ShareCapitalcore:PreviouslyStatedAmount2024-10-31 07285425core:ShareCapitalcore:PreviouslyStatedAmount2023-06-30 07285425core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-10-31 07285425core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-06-30 07285425core:PreviouslyStatedAmount2024-10-31 07285425core:PreviouslyStatedAmount2023-06-30 07285425business:SmallEntities2023-07-012024-10-31 07285425countries:EnglandWales2023-07-012024-10-31 07285425core:AdditionsToInvestments2024-10-31 07285425business:Director112023-06-30 07285425business:Director112023-07-012024-10-31 07285425business:Director112024-10-31 072854252022-07-012023-06-30 iso4217:GBP xbrli:pure
Company Registration No. 07285425 (England and Wales)
Dna-Play Limited Unaudited accounts for the period from 1 July 2023 to 31 October 2024
Dna-Play Limited Unaudited accounts Contents
Page
- 2 -
Dna-Play Limited Company Information for the period from 1 July 2023 to 31 October 2024
Director
Jacek Maklakiewicz
Company Number
07285425 (England and Wales)
Registered Office
Unit 4C Main Road Bramfield Hertford SG14 2FD
Accountants
Optics Accounting Ltd 17 Willow Pike Sutton Courtenay Abingdon OX14 4GB
- 3 -
Dna-Play Limited Statement of financial position as at 31 October 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Investments
389,666 
382,666 
Current assets
Debtors
100,880 
113,767 
Creditors: amounts falling due within one year
(36,717)
(684,123)
Net current assets/(liabilities)
64,163 
(570,356)
Net assets/(liabilities)
453,829 
(187,690)
Capital and reserves
Called up share capital
1,000 
1,000 
Profit and loss account
452,829 
(188,690)
Shareholders' funds
453,829 
(187,690)
For the period ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 27 March 2025 and were signed on its behalf by
Jacek Maklakiewicz Director Company Registration No. 07285425
- 4 -
Dna-Play Limited Notes to the Accounts for the period from 1 July 2023 to 31 October 2024
1
Statutory information
Dna-Play Limited is a private company, limited by shares, registered in England and Wales, registration number 07285425. The registered office is Unit 4C Main Road, Bramfield, Hertford, SG14 2FD.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention. These financial statements have been prepared on the basis that the company will continue to be a going concern. If this assumption is not considered to be valid then adjustments would need to be made to reduce the value of assets to their recoverable amount, to provide for any further liabilities that might arise, and to reclassify fixed assets and long term liabilities as current assets and current liabilities.
Presentation currency
The accounts are presented in £ sterling.
Investments
Investments in subsidiary undertakings are recognised at cost.
4
Investments
Subsidiary undertakings 
£ 
Valuation at 1 July 2023
382,666 
Additions
7,000 
Valuation at 31 October 2024
389,666 
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Other debtors
100,880 
113,767 
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Bank loans and overdrafts
9,430 
9,241 
Taxes and social security
27,287 
28,708 
Other creditors
- 
646,174 
36,717 
684,123 
- 5 -
Dna-Play Limited Notes to the Accounts for the period from 1 July 2023 to 31 October 2024
7
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
Jacek Maklakiewicz
85,060 
52,615 
62,250 
75,425 
85,060 
52,615 
62,250 
75,425 
During the period ending Oct 31, 2024, the company advanced £52,615 to the director and an interest of £1,785 on overdrawn DLA has been charged. The repayments during the year have amounted to £62,250. The loan is short-term and repayable on demand. The total balance of advances outstanding as at Oct 31, 2024 was £75,425.
8
Transactions with related parties
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.
9
Average number of employees
During the period the average number of employees was 0 (2023: 0).
- 6 -